EUCAST Statutes (revised May 9, 2011)

EUCAST Statutes (amended 2016-04-11) outlines the objectives, membership structure, consultation and decision process, breakpoint setting for new agents, meetings, publication policy, declarations of interests and funding of EUCAST. The statutes were originally published in November 1999 and have been amended several times since then. 



  • To form in EUCAST, under the auspices of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Centre for Disease Prevention and Control (ECDC), a network of established experts in the determination of antimicrobial breakpoints and in antimicrobial susceptibility testing.
  • To determine, review and revise European clinical breakpoints and epidemiological cut-off values for surveillance of antimicrobial resistance in close collaboration with the European Medicines Agency (EMA) and ECDC. • To promote the development and standardization of in-vitro antimicrobial susceptibility testing methods used in Europe.
  • To promote quality assurance of in-vitro antimicrobial susceptibility testing.
  • To promote education and training in antimicrobial susceptibility testing.
  • To advise ECDC and other European Union health agencies on issues related to antimicrobial susceptibility testing and detection of resistance determinants relevant to public health.
  • To collaborate with international groups, ECDC and other European Union health agencies involved in antimicrobial susceptibility testing and/or the epidemiology of antimicrobial resistance in human pathogens.
  • To work towards international consensus and harmonization of clinical breakpoints and antimicrobial susceptibility testing.